STOCK TITAN

Exponent (EXPO) VP John Pye converts RSUs; shares withheld for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Exponent Inc. executive John Pye reported routine equity compensation activity involving restricted stock units and common shares. On March 11, 2026, 5,934 vested restricted stock units were converted into 5,934 shares of common stock on a 1:1 basis, reflecting the vesting of awards originally granted on March 11, 2022.

To cover tax withholding obligations tied to this vesting, 2,384 common shares were withheld by the company at a price of $70.03 per share, a tax-related disposition rather than an open-market sale. After these transactions, Pye directly holds 29,131 shares of Exponent common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pye John

(Last) (First) (Middle)
149 COMMONWEALTH DRIVE

(Street)
MENLO PARK CA 94025

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EXPONENT INC [ EXPO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP Global Offices & Innovation
3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/11/2026 M(1) 5,934 A (2) 31,515 D
Common Stock 03/11/2026 F(3) 2,384 D $70.03 29,131 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 03/11/2026 M(1) 5,934 03/11/2026 03/11/2026 Common Stock 5,934 (2) 0 D
Explanation of Responses:
1. Reflects the conversion of shares of vested Restricted Stock Units granted on March 11, 2022 into shares of Common Stock on a 1:1 basis.
2. Not applicable.
3. Reflects shares of common stock withheld by the Company to satify the tax withholding obligations of the Reporting Person.
By: Wendy Whitehouse For: John Pye 03/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Exponent (EXPO) report for John Pye on March 11, 2026?

On March 11, 2026, Exponent VP John Pye converted 5,934 vested restricted stock units into 5,934 common shares. The company then withheld 2,384 shares at $70.03 each to cover related tax obligations, leaving him with 29,131 shares directly held.

Were John Pye’s Exponent (EXPO) transactions open-market stock sales?

No, the Form 4 shows no open-market sales by John Pye. Shares were issued through RSU vesting and some were withheld by the company to satisfy tax obligations, a non-market tax-withholding disposition rather than a discretionary sale into the market.

How many Exponent (EXPO) shares does John Pye hold after the reported Form 4 transactions?

Following the March 11, 2026 RSU vesting and tax withholding, John Pye directly holds 29,131 shares of Exponent common stock. This figure reflects the net position after converting 5,934 restricted stock units and withholding 2,384 shares for tax obligations.

What equity awards were converted in John Pye’s Exponent (EXPO) Form 4 filing?

The filing shows conversion of vested restricted stock units granted on March 11, 2022. On March 11, 2026, 5,934 of these units vested and were converted into 5,934 shares of Exponent common stock on a 1:1 basis, as described in the footnotes.

What does the tax-withholding transaction in Exponent (EXPO) VP John Pye’s Form 4 mean?

The tax-withholding entry reflects 2,384 Exponent shares withheld by the company at $70.03 per share. This satisfies John Pye’s tax obligations associated with the RSU vesting and is classified as a tax-withholding disposition, not an open-market sale of stock.
Exponent Inc

NASDAQ:EXPO

View EXPO Stock Overview

EXPO Rankings

EXPO Latest News

EXPO Latest SEC Filings

EXPO Stock Data

3.43B
48.67M
Engineering & Construction
Services-management Consulting Services
Link
United States
MENLO PARK